These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 36193067)
1. CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma. Peng Q; Huang H; Zhu C; Hou Q; Wei S; Xiao Y; Zhang Z; Sun X Oxid Med Cell Longev; 2022; 2022():8421813. PubMed ID: 36193067 [TBL] [Abstract][Full Text] [Related]
2. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma. Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202 [TBL] [Abstract][Full Text] [Related]
3. Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis. Qiao Y; Yuan F; Wang X; Hu J; Mao Y; Zhao Z Cancer Biomark; 2022; 35(2):227-243. PubMed ID: 36120772 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients. Zhuang L; Yang Z; Meng Z Biomed Res Int; 2018; 2018():7897346. PubMed ID: 30363964 [TBL] [Abstract][Full Text] [Related]
5. GTSE1, CDC20, PCNA, and MCM6 Synergistically Affect Regulations in Cell Cycle and Indicate Poor Prognosis in Liver Cancer. Zheng Y; Shi Y; Yu S; Han Y; Kang K; Xu H; Gu H; Sang X; Chen Y; Wang J Anal Cell Pathol (Amst); 2019; 2019():1038069. PubMed ID: 32082966 [TBL] [Abstract][Full Text] [Related]
6. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis. Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011 [TBL] [Abstract][Full Text] [Related]
7. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma. Dai K; Liu C; Guan G; Cai J; Wu L BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatical Analysis of Gene Expression Omnibus Database Associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 Pathways with Glioblastoma Development and Prognosis. Yang L; Zeng W; Sun H; Huang F; Yang C; Cai X; Lu Y; Zeng J; Yang K World Neurosurg; 2020 Jun; 138():e492-e514. PubMed ID: 32147549 [TBL] [Abstract][Full Text] [Related]
9. The bioinformatics and experimental analysis of the novel roles of virus infection-associated gene CDC20 for prognosis and immune infiltration in hepatocellular carcinoma. Li J; Zhang X; Yao L; Hu K Aging (Albany NY); 2022 May; 14(10):4513-4529. PubMed ID: 35622386 [TBL] [Abstract][Full Text] [Related]
10. Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes. Yan J; Cao J; Chen Z BMC Cancer; 2021 Feb; 21(1):175. PubMed ID: 33602168 [TBL] [Abstract][Full Text] [Related]
11. Identification of potential hub genes associated with the pathogenesis and prognosis of hepatocellular carcinoma via integrated bioinformatics analysis. Meng Z; Wu J; Liu X; Zhou W; Ni M; Liu S; Guo S; Jia S; Zhang J J Int Med Res; 2020 Jul; 48(7):300060520910019. PubMed ID: 32722976 [TBL] [Abstract][Full Text] [Related]
12. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related]
13. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma. Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549 [TBL] [Abstract][Full Text] [Related]
14. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases. Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537 [No Abstract] [Full Text] [Related]
15. Six Cell Cycle-related Genes Serve as Potential Prognostic Biomarkers and Correlated with Immune Infiltrates in Hepatocellular Carcinoma. Shi Y; Sang X; Deng J; Wang Y; Chen X; Lin S; Wu F; Xu A J Cancer; 2023; 14(1):9-23. PubMed ID: 36605491 [No Abstract] [Full Text] [Related]
16. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis. Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250 [TBL] [Abstract][Full Text] [Related]
17. Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion. Zhang R; Huang M; Wang H; Wu S; Yao J; Ge Y; Lu Y; Hu Q Pathol Oncol Res; 2021; 27():597527. PubMed ID: 34257549 [No Abstract] [Full Text] [Related]
18. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis. Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056 [TBL] [Abstract][Full Text] [Related]
19. Four-gene signature predicting overall survival and immune infiltration in hepatocellular carcinoma by bioinformatics analysis with RT‒qPCR validation. Guan R; Zou J; Mei J; Deng M; Guo R BMC Cancer; 2022 Jul; 22(1):830. PubMed ID: 35907846 [TBL] [Abstract][Full Text] [Related]
20. A 4-gene prognostic signature predicting survival in hepatocellular carcinoma. Chen PF; Li QH; Zeng LR; Yang XY; Peng PL; He JH; Fan B J Cell Biochem; 2019 Jun; 120(6):9117-9124. PubMed ID: 30582205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]